Immix Biopharma Inc

NASDAQ IMMX

Data sourced from iex and EODHD
Download Data

Immix Biopharma Inc Income Statement 2020 - 2024

This table shows the Income Statement for Immix Biopharma Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30
Revenue
M 0 0 0 0 0 -90 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 0 0 0 0 0 0 - - - - - - - - -
Gross Profit
M 0 0 0 0 0 -90 - - - - - - - - -
Operating Expenses
M 6 5 5 4 3 -86 - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 2 2 2 2 1 2 1 1 1 1 0 0 0 0 0
Research and Development (R&D) Expenses
M 3 3 2 2 1 2 1 1 1 0 0 0 0 0 0
Other Operating Expenses
M 0 0 0 0 0 -90 - - - - - - - - -
Costs and Expenses
M 6 5 5 4 3 4 - - - - - - - - -
Operating Income
M -6 -5 -5 -4 -3 -4 -2 -2 -1 -1 0 0 0 0 0
Interest Expense
M - 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 0 0 0 0 0 10 0 0 0 -22 0 0 -1 -1 0
EBT
M -5 -5 -4 -4 -2 -4 -2 -2 -1 -23 0 0 -1 -1 0
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -5 -5 -4 -4 -2 -4 -2 -2 -1 -23 0 0 -1 -1 0
Non-Controlling Interest
M - - - 0 1 0 0 0 0 0 0 0 0 - 0
Net Income
M - - - -4 -4 -4 -2 -2 -1 -23 0 -1 -1 - 0
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 23,438,143.00 19,922,356.00 18,578,414.00 15,038,989.00 13,897,184.00 13,887,308.00 13,924,832.00 13,881,414.00 13,830,374.00 7,575,000.00 7,200,000.00 8,774,852.00 8,774,852.00 7,575,000.00 7,575,000.00
EBITDA
M -6 -5 -4 -4 -2 -4 -2 -2 -1 -1 0 0 0 -1 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -6 -5 -4 -4 -3 -4 -2 -2 -1 -1 0 0 0 -1 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.17 -0.16 -0.16 -0.18 -0.21 -0.14 -0.11 -0.11 -0.12 -0.01 -0.33 -0.78 -0.16 -1.63 -1.50
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0
Gross Profit Margin
% - 35.70 - - - 100.00 - - - - - - - - -
Operating Income Margin
% - -112,217.60 - - - 4.24 - - - - - - - - -
Net Income Margin
% - - - - - 4.24 - - - - - - - - -
EBITDA Ratio
% - -112,153.22 - - - 4.24 - - - - - - - - -
EBIT Ratio
% - -112,217.52 - - - 4.24 - - - - - - - - -
EBT Ratio
% - -107,593.58 - - - 4.24 - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email